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NKG2D Ligation without T Cell Receptor
Engagement Triggers Both Cytotoxicity and
Cytokine Production in Dendritic Epidermal T Cells
Ayano Nitahara1, Hideki Shimura1, Akiko Ito1, Katschiro Tomiyama1, Masaaki Ito1 and Kazuhiro Kawai1
NKG2D is an activating receptor that recognizes self-ligands induced on stressed, infected, or transformed cells. In
mice, two NKG2D isoforms (NKG2D-S (short) and NKG2D-L (long)) that associate differentially with DAP10 and
DAP12 adaptor proteins exist. Differential expression of these isoforms and adaptor proteins depending on the
activating state and cell types determines distinct functional outcomes of NKG2D ligation: direct activation of
cytotoxicity in natural killer (NK) cells and cytokine production in activated NK cells, but only costimulation in
activated CD8þ T cells. Intraepithelial gd T cells of the mouse skin, termed dendritic epidermal T cells (DETCs), were
also shown to express NKG2D, but the NKG2D isoform(s) expressed in DETCs have not been determined.
Furthermore, functional outcomes of NKG2D ligation in DETCs are largely unknown, although costimulation of
DETC-mediated cytotoxicity by NKG2D was demonstrated. Here, we show that DETCs constitutively express
NKG2D-S, NKG2D-L, DAP10, and DAP12 transcripts as well as cell surface NKG2D protein. Blocking of NKG2D
inhibited DETC-mediated cytotoxicity against target cells that do not express T cell receptor ligands. Cross-linking
of NKG2D on DETCs induced IFN-g production. These findings demonstrate that DETCs constitutively express
NKG2D that acts as a primary activating receptor, and indicate its important role in cutaneous immune surveillance.
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INTRODUCTION
Intraepithelial lymphocytes of the mouse skin, termed
dendritic epidermal T cells (DETCs), uniformly express a
skin-specific invariant gd T cell receptor (TCR) composed of
Vg3Jg1Cg1 and Vd1Dd2Jd2Cd chains lacking junctional
diversity (Allison and Havran, 1991). Although the ligands
for the Vg3 TCR have not been identified, DETCs have been
shown to recognize self-antigens expressed on stressed,
damaged, or transformed keratinocytes through the TCR
in vitro (Havran et al., 1991; Tigelaar and Lewis, 1994).
TCR-mediated recognition of the self-antigens induced on
neighboring stressed, damaged, or transformed keratinocytes
may also be critical for the activation of DETCs in vivo to
exert various effector functions including downregulation of
cutaneous inflammation (Shiohara et al., 1996; Girardi et al.,
2002), wound healing (Jameson et al., 2002, 2004), main-
tenance of skin homeostasis (Sharp et al., 2005), defense
against bacterial infection (Molne et al., 2003), and tumor
surveillance (Girardi et al., 2001). Accumulating evidence
suggests, however, that TCR–ligand interactions are crucial
for the maintenance of DETCs in the skin (Mallick-Wood
et al., 1998; Aono et al., 2000; Hara et al., 2000; Minagawa
et al., 2001; Jameson et al., 2004) as well as for the positive
selection of DETC precursors in the thymus (Ferrero et al.,
2001; Xiong et al., 2004). Thus, at least low levels of the Vg3
TCR ligands would be constitutively expressed on normal
keratinocytes in vivo. The autoreactivity of DETCs may be
regulated by negative signals mediated through the inhibitory
receptors, Ly49E and CD94-NKG2A (Van Beneden et al.,
2002). In addition, DETCs express several activating receptors
other than TCR, including 2B4 (Schuhmachers et al.,
1995a, b), Toll-like receptor 4 (Shimura et al., 2005), and
NKG2D (Girardi et al., 2001; Jamieson et al., 2002). Precise
roles of these receptors in the activation and effector
functions of DETCs in vivo remain to be determined.
NKG2D is a C-type lectin-like activating receptor that
recognizes several major histocompatibility complex class I-
related self-ligands induced or upregulated on stressed,
infected, or transformed cells (Raulet, 2003). Whereas
NKG2D is expressed on most natural killer (NK) cells,
CD8þ ab T cells, and gd T cells in humans (Bauer et al.,
1999; Groh et al., 2001; Roberts et al., 2001; Maasho et al.,
2005), its expression in mice is restricted to naive and
activated NK cells, activated (but not naive) CD8þ T cells, a
subpopulation of NKT cells, and certain gd T cell subsets
including DETCs (Ho et al., 2002; Jamieson et al., 2002).
Adaptor proteins that associate with and transduce signals
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from NKG2D are also different between humans and mice. In
mice, two alternative splicing isoforms of NKG2D exist:
NKG2D-S (short), associating with DAP10 and DAP12
adaptor proteins, and NKG2D-L (long), associating exclu-
sively with DAP10 (Diefenbach et al., 2002). In humans, only
the counterpart of mouse NKG2D-L isoform that is structu-
rally incapable of associating with DAP12 is expressed, and
NKG2D signals are mediated solely through DAP10
(Wu et al., 1999, 2000; Billadeau et al., 2003; Andre et al.,
2004; Rosen et al., 2004). NKG2D ligation directly triggers
cytotoxicity in mouse and human NK cells and cytokine
production in activated mouse NK cells (Diefenbach et al.,
2000; Wu et al., 2000; Ho et al., 2002; Jamieson et al., 2002;
Ogasawara et al., 2003), but provides only costimulatory
signals in mouse and human CD8þ T cells (Groh et al., 2001;
Jamieson et al., 2002). These distinct functional outcomes of
NKG2D ligation depending on the activation state and cell
types are explained by differential expression of NKG2D
(isoforms) and adaptor proteins (Raulet, 2003). Naive mouse
NK cells express only NKG2D-L isoform, but on activation
both NKG2D-S and NKG2D-L are expressed (Diefenbach
et al., 2002). Either DAP10 or DAP12 signaling is sufficient to
trigger cytotoxicity in mouse NK cells (Gilfillan et al., 2002;
Zompi et al., 2003), but cytokine production is DAP12
dependent and requires activation-induced NKG2D-S ex-
pression (Diefenbach et al., 2002; Zompi et al., 2003). In
human NK cells, DAP10 signaling is also sufficient to initiate
NKG2D-dependent cytotoxicity, but insufficient to induce
cytokine production (Wu et al., 2000; Billadeau et al., 2003).
Although activated mouse CD8þ T cells express both
NKG2D-S and NKG2D-L, mouse CD8þ T cells do not
express DAP12 (Diefenbach et al., 2002; Gilfillan et al.,
2002) and both NKG2D isoforms associating with DAP10
serve as a costimulatory receptor (Diefenbach et al., 2002;
Jamieson et al., 2002). In human CD8þ T cells, NKG2D in
association with DAP10 also acts only as a costimulatory
receptor (Groh et al., 2001; Maasho et al., 2005).
DETCs were shown to express NKG2D (Girardi et al.,
2001; Jamieson et al., 2002), but the NKG2D isoform(s)
expressed in DETCs have not been determined. Furthermore,
functional outcomes of NKG2D ligation in DETCs are largely
unknown, although costimulation of DETC-mediated cyto-
toxicity by NKG2D was demonstrated (Girardi et al., 2001). In
this study, we analyzed the expression of NKG2D isoforms
and functional outcomes of NKG2D ligation in DETCs. Here,
we show that DETCs constitutively express both NKG2D-S
and NKG2D-L isoforms as well as DAP10 and DAP12 adaptor
proteins, and that NKG2D ligation without TCR engagement
triggers both cytotoxicity and cytokine production in DETCs.
RESULTS
Constitutive expression of both NKG2D-S and NKG2D-L
isoforms as well as DAP10 and DAP12 adaptor proteins in
DETCs
To determine the expression of NKG2D-S and NKG2D-L
isoforms and associating DAP10 and DAP12 adaptor proteins
in DETCs, freshly isolated naive DETCs and activated DETCs,
which had been stimulated with immobilized anti-TCR
monoclonal antibody (mAb) and expanded in short-term
cultures in the presence of IL-2, were analyzed by reverse
transcriptase-polymerase chain reaction for these molecules
(Figure 1a). Because CD8þ T cells do not express DAP12 and
only activated (but not naive) NK cells express NKG2D-S
(Diefenbach et al., 2002), we used IL-2-activated NK cells as
a positive control (Figure 1a). Both NKG2D-S and NKG2D-L
as well as DAP10 and DAP12 transcripts were detected
in naive DETCs (Figure 1a). The activation of DETCs did
not result in significant upregulation of the mRNA expression
levels of these molecules (Figure 1a). Therefore, the
transcripts detected in the naive DETC preparations would
not be attributable to the minor DETC subpopulation that had
been ‘‘activated’’ in vivo or during isolation or purification
steps. These results suggest that unlike NK cells or CD8þ T
cells, DETCs constitutively express both NKG2D-S and
NKG2D-L isoforms as well as DAP10 and DAP12 adaptor
proteins.
NKG2D-S, NKG2D-L, DAP10, and DAP12 transcripts were
also detected in resting AYA-1 and AKD3 DETC line cells (data
not shown). From the cell lysates of these DETC lines, both
DAP10 and DAP12 adaptor proteins were co-immunopreci-
pitated with NKG2D (Figure 1b). As only NKG2D-S isoform
can associate with DAP12 (Diefenbach et al., 2002), these
results demonstrate that the resting DETC line cells express at
least NKG2D-S, DAP10, and DAP12 proteins.
Cell surface expression of NKG2D protein on DETCs
Consistent with previous observations (Jamieson et al., 2002),
cell surface expression of NKG2D protein was detected
on freshly isolated DETCs by flow cytometry (Figure 2a).
However, the NKG2D expression levels on DETCs were
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Figure 1. Expression of NKG2D-S, NKG2D-L, DAP10, and DAP12 in DETCs.
(a) Total RNA was extracted from IL-2-activated NK cells (positive control),
naive DETCs, and activated DETCs. The amount of cDNA was normalized
according to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA expression, and serially diluted cDNA was analyzed by reverse
transcriptase (RT)-polymerase chain reaction for NKG2D-S, NKG2D-L,
DAP10, and DAP12 mRNA expression. RT-negative controls were also
included. Representative data from three independent experiments are
shown. (b) Digitonin lysates from resting AYA-1 and AKD3 DETCs were
immunoprecipitated (IP) with anti-NKG2D antibody or control goat IgG,
and immunoblotted (IB) with anti-DAP10 or anti-DAP12 antibody. No signal
was detected by immunoblotting with control goat IgG (not shown).
Representative data from two independent experiments are shown.
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much lower than that shown in the prior study (Jamieson
et al., 2002) and than the expression levels on freshly isolated
or IL-2-activated NK cells (Figure 2b). We found that cell
surface NKG2D was trypsin sensitive, because treatment of
NK cells with trypsin resulted in a marked downregulation of
NKG2D expression (data not shown). Therefore, the different
levels of NKG2D expression on freshly isolated DETCs
observed between the two studies might be explained by
the difference in trypsinization protocols used for epidermal
cell isolation. Supporting this explanation, overnight cultures
of freshly isolated DETCs allowed recovery of surface
NKG2D expression (Figure 2a). This NKG2D upregulation
would not be owing to activation, because most DETCs
remained to be negative for an activation marker CD25 after
overnight cultures (Figure 2a). In contrast, activated DETCs
uniformly expressed NKG2D and CD25 (Figure 2a).
NKG2D expression was also detected on AYA-1 and
AKD3 DETC line cells (Figure 2c). Although NKG2D
expression appeared to be slightly upregulated on activation
(Figure 2c), statistically significant differences in the NKG2D
expression levels (represented by the mean fluorescence
intensity) between resting and activated DETC line cells were
not detected (for AYA-1, P¼0.434, N¼ 3; for AKD3,
P¼0.177, N¼ 3).
NKG2D ligation without TCR engagement triggers cytotoxicity
in DETCs
It was reported that lysis of the transformed keratinocyte line
PDV cells by DETCs was partially blocked with soluble
NKG2D ligand, anti-NKG2D polyclonal antibody, or anti-TCR
mAb (Girardi et al., 2001). However, it remained unclear
whether NKG2D signaling was stimulatory or costimulatory for
the DETC-mediated cytotoxicity, because PDV cells expressed
both NKG2D ligands and the Vg3 TCR ligands (Girardi et al.,
2001). Therefore, we used the B cell lymphoma line A20 cells
that express NKG2D ligands (Figure S1) (Diefenbach et al.,
2000) but not the Vg3 TCR ligands (Reardon et al., 1995;
Aydintug et al., 2004) as target cells in cytotoxicity assays.
DETCs could efficiently kill A20 cells and the lysis was
partially blocked with anti-NKG2D mAb but not with anti-TCR
mAb (Figure 3a). By contrast, the same anti-TCR mAb
completely blocked DETC-mediated lysis of the transformed
keratinocyte line Pam 212 cells (Figure 3b) that express the Vg3
TCR ligands (Havran et al., 1991; Aydintug et al., 2004) but not
NKG2D ligands (Figure S1). These results demonstrate that the
lysis of A20 cells by DETCs was at least partially dependent on
NKG2D signaling, but independent of TCR signaling.
In accordance with prior reports (Ho et al., 2002; Jamieson
et al., 2002), the NKG2D mAb could also partially block NK
cell-mediated killing of A20 cells (Figure 3c), but failed to
inhibit the lysis of EL4 cells (Figure 3d) that do not express
NKG2D ligands (Figure S1) (Diefenbach et al., 2000),
confirming the specificity of the NKG2D mAb.
NKG2D ligation without TCR engagement triggers cytokine
production in DETCs
As DETCs expressed both NKG2D-S and DAP12 (Figure 1a
and b), which are strictly required for NKG2D-initiated
cytokine production in activated NK cells (Diefenbach et al.,
2002; Zompi et al., 2003), we next determined whether
NKG2D ligation can directly trigger cytokine production in
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Figure 2. Cell surface expression of NKG2D protein on DETCs. (a) Freshly
isolated epidermal cells, epidermal cells cultured overnight, and activated
DETCs were stained with anti-Vg3 TCR and anti-NKG2D or anti-CD25 mAbs.
Quadrant settings were determined by staining with isotype control mAbs.
The percentages of cells for a given phenotype are shown. Representative
profiles from three independent experiments are shown. (b) Freshly isolated
spleen cells and IL-2-activated NK cells were stained with anti-CD49b and
anti-NKG2D mAbs. Quadrant settings were determined by staining with
isotype control mAbs. The percentages of cells for a given phenotype are
shown. Representative profiles from three independent experiments are
shown. (c) Resting and activated AYA-1 and AKD3 DETCs were stained with
anti-Vg3 TCR and anti-NKG2D mAbs. Quadrant settings were determined by
staining with isotype control mAbs. The percentages of cells for a given
phenotype are shown. Representative profiles from three independent
experiments are shown.
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DETCs. Stimulation of DETCs with immobilized anti-NKG2D
mAb induced IFN-g production (Figure 4a). The levels of IFN-g
secreted by DETCs in response to NKG2D ligation were
comparable or even superior to that in response to TCR cross-
linking and IL-12þ IL-18 (Figure 4a). A similar response was
also observed in activated NK cells (positive control)
stimulated by NKG2D cross-linking and IL-12þ IL-18 (Figure
4b). Thus, as in activated NK cells, NKG2D ligation alone
was sufficient for full activation of DETCs to produce IFN-g.
DISCUSSION
In this study, we have shown that DETCs constitutively
express NKG2D-S, NKG2D-L, DAP10, and DAP12 tran-
scripts. Although we could not directly demonstrate the
presence of NKG2D-S–DAP10, NKG2D-S–DAP12, or
NKG2D-L–DAP10 protein complex in naive DETCs by
immunoprecipitation because of the low yields of purified
naive DETCs, we have confirmed the presence of
NKG2D–DAP10 and NKG2D(-S)–DAP12 protein complexes
in resting DETC line cells. We have also confirmed cell
surface expression of NKG2D protein on freshly isolated
DETCs. Notably, constitutive expression of the NKG2D-S
isoform may be a distinct feature of DETCs, because NKG2D-S
expression in NK cells and CD8þ T cells requires activation
(Diefenbach et al., 2002). NKG2D-initiated cytokine produc-
tion as well as efficient ex vivo cytotoxicity depend on the
DAP12 signaling through NKG2D-S in activated NK cells
(Diefenbach et al., 2002; Zompi et al., 2003). Therefore, the
NKG2D-S associating with DAP12 on naive DETCs may also
act as a primary activating receptor that can trigger both
cytotoxicity and cytokine production in the absence of TCR
signaling. This possibility cannot be directly examined ex
vivo, because the TCR on naive DETCs prepared from freshly
isolated epidermal cells had already engaged by the self-
antigens induced on damaged keratinocytes (Hara et al.,
2000) or by anti-TCR mAb used for purification. NKG2D-
dependent and TCR-independent lysis of A20 target cells by
resting DETC line cells is consistent with direct stimulation of
DETCs through NKG2D, but the lysis was inhibited only
partially with anti-NKG2D mAb. As in NK cells (Lanier,
2005), activation of DETCs may be tuned by the balance
between positive and negative signals through various
activating and inhibitory receptors. Therefore, additional
receptor–ligand interactions might be involved in the DETC-
mediated lysis of A20 cells and NKG2D might serve as a
synergistic or costimulatory receptor rather than the primary
activating receptor. Nevertheless, the finding that NKG2D
ligation with immobilized anti-NKG2D mAb alone was
sufficient to induce IFN-g production in resting DETC line
cells indicates that NKG2D can directly stimulate DETC
activation. Recent transcriptional profiling of intestinal
intraepithelial T cells revealed that these cells represent
constitutively activated (yet resting) phenotype, which
enables them to exert effector functions quickly after
receiving additional activating signals (Fahrer et al., 2001;
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Figure 3. NKG2D ligation triggers DETC-mediated killing of target cells that
do not express TCR ligands. (a, b) The cytotoxicity of resting AYA-1 DETCs
and (c, d) IL-2-activated NK cells against (a, c) A20, (b) Pam 212, and (d) EL4
target cells was assessed. Effector cells were pre-incubated with anti-NKG2D,
anti-TCR, or control mAb. Isotype-matched mAbs for both anti-NKG2D and
anti-TCR mAbs were added to the control in (a). Data are expressed as mean
specific lysis7SD (%) at the indicated effector/target (E/T) ratios. Represen-
tative data from three independent experiments are shown. Significant
inhibition of the cytotoxicity was evident only with anti-NKG2D mAb in
(a) (P¼0.005), anti-TCR mAb in (b) (Po0.001), and anti-NKG2D mAb in
(c) (Po0.001).
Co
nt
ro
l
An
ti-
N
KG
2D
An
ti-
TC
R
IL
-1
2+
IL
-1
80
200
400
600
800
1,000
Co
nt
ro
l
An
ti-
N
KG
2D
IL
-1
2+
IL
-1
8
DETCs NK cells
IF
N
-
 
(pg
/m
l)
0
200
400
600
800
1,000
IF
N
-
 
(pg
/m
l)
a b
Figure 4. NKG2D ligation with immobilized anti-NKG2D mAb induces IFN-c
production in DETCs. (a) Resting AKD3 DETCs were cultured in the absence
(control) or presence of immobilized anti-NKG2D or anti-TCR mAb, or
IL-12þ IL-18, and IFN-g levels of the supernatants were determined. To block
Fc receptor-dependent activation, responder cells were pre-incubated with
soluble anti-CD16/CD32 mAb. Each bar represents the mean and SD of
triplicate cultures. Representative data from three independent experiments
are shown. For control versus anti-NKG2D, anti-TCR, or IL-12þ IL-18
stimulation, Po0.001; for anti-NKG2D stimulation versus anti-TCR or
IL-12þ IL-18 stimulation, Po0.001. (b) IL-2-activated NK cells were
stimulated as in (a), except that anti-TCR stimulation was omitted. Each bar
represents the mean and SD of triplicate cultures. Representative data from
three independent experiments are shown. For control versus anti-NKG2D
or IL-12þ IL-18 stimulation, Po0.001.
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Shires et al., 2001). DETCs would also be ‘‘ready-to-go’’ cells,
and constitutive expression of NKG2D-S–DAP12 at the naive
state may allow DETCs to respond rapidly to stressed,
infected, or transformed cells in vivo through NKG2D-
dependent recognition of inducible self-ligands even in the
absence of TCR-mediated recognition.
TCRd-deficient mice, which lack DETCs, are highly
susceptible to multiple regimens of cutaneous carcinogenesis
(Girardi et al., 2001). NKG2D ligands are induced in the skin
by topical application of chemical carcinogens in vivo
(Girardi et al., 2001). Based on the in vitro finding that
DETC line cells killed transformed keratinocytes by a
mechanism that was sensitive to blockade of both NKG2D
and TCR (Girardi et al., 2001), cytotoxicity against skin
cancers was proposed as the primary role of DETCs in the
tumor surveillance. However, direct evidence for an in vivo
cytotoxicity of DETCs was lacking. Indeed, although freshly
isolated DETCs contain perforin (Kobata et al., 1990), they do
not exhibit cytotoxicity ex vivo, and their acquisition of
cytotoxicity generally requires 10–14 days of in vitro cultures
in the presence of IL-2 (Nixon-Fulton et al., 1988; Kaminski
et al., 1993). As freshly isolated DETCs have capacity
to produce IFN-g (Sugaya et al., 1999), NKG2D-dependent
IFN-g production by DETCs may also contribute to tumor
surveillance. Supporting this possibility, an important role of
gd T cells for providing an early source of IFN-g in tumor
immunity was reported (Gao et al., 2003).
In conclusion, we have demonstrated that DETCs con-
stitutively express both NKG2D-S and NKG2D-L isoforms,
and NKG2D ligation without TCR engagement triggers both
cytotoxicity and cytokine production in resting DETC line
cells. Although these findings indicate an important role of
NKG2D in DETC activation, the physiological roles of this
receptor in DETC-mediated immune surveillance in vivo
remain to be addressed in future studies.
MATERIALS AND METHODS
Mice
C57BL/6 mice were purchased from Charles River Japan (Yokohama,
Japan). Female mice were used at 6–8 weeks of age. All procedures
have been approved by the Animal Care Committee of Niigata
University following the institutional guidelines.
Cells
Epidermal cell suspensions were prepared as described (Kawai et al.,
1998). Briefly, the ear skin was treated with 1% trypsin (Invitrogen,
Carlsbad, CA) in phosphate-buffered saline for 40 minutes at 371C.
The epidermis was separated and collected in Iscove’s modified
Dulbecco’s medium (IMDM) (Invitrogen) supplemented with 10%
fetal calf serum (FCS) (JRH Biosciences, Lenexa, KS) and 0.025%
deoxyribonuclease I (Sigma-Aldrich, St Louis, MO). Single-cell
suspensions were obtained by mechanical agitation and filtration
through 70 and 30mm nylon meshes. In some experiments, freshly
isolated epidermal cells were cultured overnight in IMDM supple-
mented with 10% FCS and 50mM 2-mercaptoethanol (Invitrogen) to
allow surface re-expression of trypsin-sensitive molecules. Viable
cells were enriched by Lympholyte-M (Cedarlane Laboratories,
Hornby, Canada) density-gradient centrifugation before use in assays.
Naive DETCs were purified from freshly isolated epidermal cells
by positive magnetic selection. After pre-incubation with anti-CD16/
CD32 mAb (clone 2.4G2; BD Biosciences, San Jose, CA), cells were
stained with phycoerythrin (PE)-conjugated anti-Vg3 TCR mAb
(clone 536; BD Biosciences), followed by incubation with magnetic
particles conjugated with anti-PE mAb (BD IMag Anti-PE Particles-
DM; BD Biosciences). The labeled cells were isolated using BD
IMagnet (BD Biosciences) according to the manufacturer’s instruc-
tions. The resulting cell population was 495% pure Vg3 TCRþ
DETCs (Figure S2).
Activated DETCs were prepared by stimulating freshly isolated
epidermal cells with immobilized anti-TCR mAb. Epidermal cells
(2–5 105) were incubated for 2 days in 96-well plates pre-coated
with 10mg/ml anti-gd TCR mAb (UC7-13D5; BD Biosciences),
followed by expansion for additional 10 days in IMDM supplemented
with 10% FCS, 50mM 2-mercaptoethanol, and 10 ng/ml recombinant
mouse IL-2 (R&D Systems, Minneapolis, MN). The resulting cell
population was 495% pure Vg3 TCRþ DETCs (Figure 2a, Figure S2).
Generation of the DETC line AYA-1 has been described elsewhere
(Shimura et al., 2005). The DETC line AKD3 was established by
stimulating epidermal cells isolated from adult female C57BL/6 mice
with 10mg/ml immobilized anti-gd TCR mAb (UC7-13D5) in IMDM
supplemented with 10% FCS, 50mM 2-mercaptoethanol, and 10 ng/ml
IL-2. The DETC lines were maintained in IMDM supplemented with
10% FCS, 50mM 2-mercaptoethanol, and 10 ng/ml IL-2, and re-
stimulated with 1mg/ml concanavalin A (Sigma-Aldrich) every 2
weeks. Cells ‘‘rested’’ for at least 1 week after the last stimulation were
used as resting DETCs. For activation, resting DETCs were stimulated
with 10mg/ml immobilized anti-gd TCR mAb (UC7-13D5) for
24 hours. At the time of use, cells were harvested by a 3-minute
incubation with 1 mM EDTA in phosphate-buffered saline.
Spleen cell suspensions were obtained by teasing the spleens and
passing through a 70 mm nylon mesh. Erythrocytes were lysed by
ammonium chloride treatment. To generate IL-2-activated NK cells,
freshly isolated spleen cells were cultured for 4 days in IMDM
supplemented with 10% FCS, 50 mM 2-mercaptoethanol, and 200 ng/
ml IL-2, and NK cells were enriched by negative magnetic selection
using BD IMag Mouse NK Cell Enrichment Set-DM (BD Bio-
sciences). In brief, cells were stained with biotin-conjugated mAbs
specific for CD4 (GK1.5), CD5 (53–7.3), CD8a (53–6.7), CD19
(1D3), CD24 (M1/69), Gr-1 (RB6-8C5), and TER-119, followed by
incubation with streptavidin-conjugated magnetic particles (BD
IMag Streptavidin Plus Particles-DM; BD Biosciences). After deple-
tion of the labeled cells using BD IMagnet, the purity of the
CD49bþCD3 NK cells was 65–75%.
The B cell lymphoma line A20, transformed keratinocyte line
Pam 212, and T cell lymphoma line EL4 were grown in IMDM
supplemented with 10% FCS.
Reverse transcriptase-polymerase chain reaction
Total RNA was extracted from the cells and reverse transcribed using
random hexamers as described (Kawai et al., 1998). Glyceralde-
hyde-3-phosphate dehydrogenase housekeeping gene expression
levels in each cDNA preparation were semiquantified as described
(Siebert and Larrick, 1993). The amount of cDNA was normalized
according to the glyceraldehyde-3-phosphate dehydrogenase mRNA
levels, and fivefold serial dilutions of cDNA were amplified using
specific primers. The primers for glyceraldehyde-3-phosphate
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dehydrogenase, NKG2D-S, NKG2D-L, DAP10, and DAP12 were
described elsewhere (Sabath et al., 1990; Diefenbach et al., 2002;
Ogasawara et al., 2003). Polymerase chain reaction conditions for
30 cycles were 941C for 45 seconds, 551C for 45 seconds, and 721C
for 1.5 minutes. Polymerase chain reaction products were separated
on 1.5% agarose gels and visualized with ethidium bromide.
Immunoprecipitation and immunoblotting
Cells (1 107) were lysed in digitonin lysis buffer containing 1%
digitonin (EMD Biosciences, San Diego, CA), 0.12% Triton X-100,
150 mM NaCl, 20 mM triethanolamine, 1 mM EDTA, and the Complete
protease inhibitor cocktail (Roche, Mannheim, Germany), pH 8.0.
Immunoprecipitation was carried out by incubation with Protein A/G
Plus-Agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA) that
were pre-coated with goat anti-NKG2D polyclonal antibody (V-14;
Santa Cruz Biotechnology) or control goat IgG (Santa Cruz
Biotechnology). Immunoprecipitates were separated by SDS-PAGE
and transferred to polyvinylidene difluoride membranes. The mem-
brane was immunoblotted with 2mg/ml goat anti-DAP10 (M-19; Santa
Cruz Biotechnology) or anti-DAP12 (A20; Santa Cruz Biotechnology)
polyclonal antibody or control goat IgG. After incubation with 0.2mg/
ml alkaline phosphatase-conjugated anti-goat IgG antibody (Santa
Cruz Biotechnology), the membrane was developed with nitroblue
tetrazolium chloride/5-bromo-4-chloro-3-indolyl-phosphate (Roche).
Flow cytometry
Cells were resuspended in phosphate-buffered saline supplemented
with 2% FCS, 0.1% NaN3, and 20 mM EDTA. After pre-incubation
with anti-CD16/CD32 mAb (2.4G2), cells were stained with
saturating amounts of the following mAbs: FITC- or PE-conju-
gated anti-Vg3 TCR (536), biotin-conjugated anti-NKG2D (C7;
eBioscience, San Diego, CA), biotin-conjugated anti-CD25 (7D4;
BD Biosciences), PE-conjugated anti-CD49b (DX5; BD Biosciences),
FITC-conjugated anti-I-Abb (AF6-120.1; BD Biosciences), and FITC-,
biotin-, or PE-conjugated isotype control mAbs (BD Biosciences or
eBioscience). Biotin-conjugated mAbs were visualized with strepta-
vidin-PE (Southern Biotechnology, Birmingham, AL) or streptavidin-
Quantum Red conjugate (Sigma-Aldrich). Expression of the NKG2D
ligands was determined with NKG2D tetramers that were multi-
merized with streptavidin-PE (a gift from Y. Ikarashi, National Cancer
Center, Tokyo, Japan). After gating on forward and side scatters and
propidium iodide, viable cells were analyzed using the FACScan
flow cytometer with the CellQuest program (BD Biosciences).
Cytotoxicity assay
Effector cells and target cells (1 104) were seeded in 96-well plates
at the indicated effector/target ratios in duplicate, and coincubated
for 4 hours in IMDM supplemented with 1% FCS. Effector cells were
pre-incubated for 30 minutes with 10 mg/ml anti-NKG2D (191004;
R&D Systems), anti-gd TCR (UC7-13D5), or control rat IgG2b (A95-1;
BD Biosciences; for anti-NKG2D) and/or hamster IgG3 (A19-4;
BD Biosciences; for anti-gd TCR) mAb before adding target cells. The
lactate dehydrogenase activity released in the supernatants was
quantified by colorimetric assay using Cytotoxicity Detection Kit
(Roche). The spontaneous release was less than 1% of the maximum
release. Specific lysis was calculated as ([experimental relea-
seeffector cell control releasespontaneous release]/[maximum
releasespontaneous release]) 100 (%).
Cytokine production assay
After pre-incubation with anti-CD16/CD32 mAb (2.4G2), cells
(1 105) were seeded in 96-well plates in IMDM supplemented
with 10% FCS, and stimulated for 24 hours with 10 mg/ml
immobilized anti-NKG2D (191004) or anti-gd TCR mAb (UC7-
13D5), or 10 ng/ml recombinant mouse IL-12 (PeproTech, London,
UK)þ 100 ng/ml recombinant mouse IL-18 (MBL, Nagoya, Japan).
IFN-g levels of the supernatants were measured using an ELISA kit
(R&D Systems).
Statistical analysis
Differences in the mean fluorescence intensity between resting and
activated DETC line cells were evaluated by the paired t-test.
Repeated-measures analysis of variance was used to compare the
cytotoxicity curves, with different effector/target ratios serving as
repeated measures. One-way analysis of variance with a post hoc
multiple comparison test (Turkey’s honestly significant difference
procedure) was used to determine the significance of differences in
the IFN-g levels. All statistical analyses were performed using JMP
(SAS Institute, Cary, NC). Differences were considered significant if
two-tailed P-values were o0.05.
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